These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32566547)

  • 1. Effect of Melatonin as an Antioxidant Drug to Reverse Hepatic Steatosis: Experimental Model.
    Martínez Soriano B; Güemes A; Pola G; Gonzalo A; Palacios Gasós P; Navarro AC; Martínez-Beamonte R; Osada J; García JJ
    Can J Gastroenterol Hepatol; 2020; 2020():7315253. PubMed ID: 32566547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of melatonin's therapeutic effectiveness against hepatic steatosis induced by a high-carbohydrate high-fat diet in rats.
    Dorranipour D; Pourjafari F; Malekpour-Afshar R; Basiri M; Hosseini M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2971-2985. PubMed ID: 37864588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
    Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
    J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant properties of tea blunt ROS-dependent lipogenesis: beneficial effect on hepatic steatosis in a high fat-high sucrose diet NAFLD obese rat model.
    Braud L; Battault S; Meyer G; Nascimento A; Gaillard S; de Sousa G; Rahmani R; Riva C; Armand M; Maixent JM; Reboul C
    J Nutr Biochem; 2017 Feb; 40():95-104. PubMed ID: 27866076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
    Jeong MJ; Kim SR; Jung UJ
    Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of
    Ghaeni Pasavei A; Mohebbati R; Jalili-Nik M; Mollazadeh H; Ghorbani A; Nosrati Tirkani A; Taraz Jamshidi S; Hashemy SI; Heidarian Miri H; Soukhtanloo M
    Drug Chem Toxicol; 2021 Jan; 44(1):75-83. PubMed ID: 33319629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of eicosapentaenoic acid on hepatic dyslipidemia and oxidative stress in high fat diet-induced steatosis.
    Hirotani Y; Ozaki N; Tsuji Y; Urashima Y; Myotoku M
    Int J Food Sci Nutr; 2015; 66(5):569-73. PubMed ID: 26017323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silybum marianum oil attenuates hepatic steatosis and oxidative stress in high fat diet-fed mice.
    Zhu SY; Jiang N; Yang J; Tu J; Zhou Y; Xiao X; Dong Y
    Biomed Pharmacother; 2018 Apr; 100():191-197. PubMed ID: 29428667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
    Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression.
    Cheng K; Song Z; Zhang H; Li S; Wang C; Zhang L; Wang T
    Med Mol Morphol; 2019 Dec; 52(4):187-197. PubMed ID: 30673851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte-specific PKCβ deficiency protects against high-fat diet-induced nonalcoholic hepatic steatosis.
    Shu Y; Hassan F; Coppola V; Baskin KK; Han X; Mehta NK; Ostrowski MC; Mehta KD
    Mol Metab; 2021 Feb; 44():101133. PubMed ID: 33271332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Lactalbumin Peptide Asp-Gln-Trp Ameliorates Hepatic Steatosis and Oxidative Stress in Free Fatty Acids-Treated HepG2 Cells and High-Fat Diet-Induced NAFLD Mice by Activating the PPARα Pathway.
    Chen H; Ma Y; Qi X; Tian J; Ma Y; Niu T
    Mol Nutr Food Res; 2023 Aug; 67(16):e2200499. PubMed ID: 37354055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tangeretin improves hepatic steatosis and oxidative stress through the Nrf2 pathway in high fat diet-induced nonalcoholic fatty liver disease mice.
    Ke Z; Tan S; Li H; Jiang S; Li Y; Chen R; Li M
    Food Funct; 2022 Mar; 13(5):2782-2790. PubMed ID: 35171164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways.
    You L; Wang T; Li W; Zhang J; Zheng C; Zheng Y; Li S; Shang Z; Lin J; Wang F; Qian Y; Zhou Z; Kong X; Gao Y; Sun X
    J Ethnopharmacol; 2024 Jul; 329():118165. PubMed ID: 38588984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats.
    Pan M; Song YL; Xu JM; Gan HZ
    J Pineal Res; 2006 Aug; 41(1):79-84. PubMed ID: 16842545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acupuncture improves hepatic lipid metabolism by suppressing oxidative stress in obese nonalcoholic fatty liver disease rats].
    Wang HY; Liang CM; Cui JW; Pan L; Hu H; Fang HJ
    Zhen Ci Yan Jiu; 2019 Mar; 44(3):189-94. PubMed ID: 30945501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model.
    Sangineto M; Bukke VN; Bellanti F; Tamborra R; Moola A; Duda L; Villani R; Romano AD; Serviddio G
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33671262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
    Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
    Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.